3. Hacke W, Kaste M, Fieschl C, Toni D, Lesaffre E, von Kummer R, et al, for the European
Cooperative Acute Stroke Study (ECASS) Group. Intravenous thrombolysis with recombinant …

3. Hacke W, Kaste M, Fieschl C, Toni D, Lesaffre E, von Kummer R, et al, for the European
Cooperative Acute Stroke Study (ECASS) Group. Intravenous thrombolysis with recombinant …

[Role of thrombolysis in stroke]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …

The results of the National Institute of Neurological Disorders and Stroke (NINDS) rtPA
Stroke Study [1] provided clear evidence that tPA can be effective under specific …

Karolinska Stroke Update is an annual meeting of European stroke experts. The agenda
includes a few important topics in which major progress has occurred or in which there is a …

Background. Thrombolytic therapy for acute ischemic stroke has been approached
cautiously because there were high rates of intracerebral hemorrhage in early clinical trials …

Acute ischemic stroke is the third major cause of death in developed countries, and a major
cause of disability. Despite a very poor prognosis, no treatment has demonstrated an …

3. Hacke W, Kaste M, Fieschl C, Toni D, Lesaffre E, von Kummer R, et al, for the European
Cooperative Acute Stroke Study (ECASS) Group. Intravenous thrombolysis with recombinant …

Although 8 yr have passed since the Food and Drug Administration (FDA) released tissue
plasminogen activator (t-PA) for use in the United States to treat patients with acute ischemic …

Life is short, and Art long; the crisis fleeting; experience perilous, and decision difficult. The
physician must not only be prepared to do what is right himself, but also to make the patient …